Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2023-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a58c8d2382f54d719e14f0ad7d512fa5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Zhen Gao |e author |
| 700 | 1 | 0 | |a Shujie Huang |e author |
| 700 | 1 | 0 | |a Sichao Wang |e author |
| 700 | 1 | 0 | |a Dezhao Tang |e author |
| 700 | 1 | 0 | |a Wei Xu |e author |
| 700 | 1 | 0 | |a Ruijie Zeng |e author |
| 700 | 1 | 0 | |a Guibin Qiao |e author |
| 245 | 0 | 0 | |a Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply |
| 260 | |b Elsevier, |c 2023-10-01T00:00:00Z. | ||
| 500 | |a 2666-6065 | ||
| 500 | |a 10.1016/j.lanwpc.2023.100927 | ||
| 546 | |a EN | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n The Lancet Regional Health. Western Pacific, Vol 39, Iss , Pp 100927- (2023) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2666606523002456 | |
| 787 | 0 | |n https://doaj.org/toc/2666-6065 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a58c8d2382f54d719e14f0ad7d512fa5 |z Connect to this object online. |